USPTO serial 85562204
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Westlake Village, CA
Westlake Village, CA
Westlake Village, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christine M. Baker
CHRISTINE M. BAKER MINTZ LEVIN COHN FERRIS GLOVSKY & POPEO, PC666 3RD AVE FL 24NEW YORK, NY 10017-4040UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibacterial pharmaceuticals; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; homeopathic pharmaceuticals for use in the treatment of sinusitis; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalers filled with anti-infectives; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations ; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of sinusitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases and cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, namely, anti-infectives; synthetic peptides for the treatment of sinus conditions and diseases; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry | SECTION 8 - CANCELLED | — |
| 035 | Retail pharmacy services; retail store pharmacy services in the field of prescription drugs; mail order pharmacy services; mail order services featuring pharmaceuticals; specialty pharmaceutical distributorship services; pharmaceutical cost management for the health care benefit plans of others; retail and online retail store pharmacy services in the field of prescription drugs, healthcare and beauty products; retail store and mail order pharmacy services in the field of prescription drugs and the distribution of drug therapy information in connection therewith; retail store services, namely, pharmacy, drug and general merchandise store services; mail order of pharmaceuticals, specialty pharmaceutical distributorship services; pharmaceutical cost management for health care benefit plans for others; administering pharmacy reimbursement programs and services; promoting public awareness of the value of using generic drugs; processing mail order prescription drug refill orders in retail and central fill pharmacies; processing online and telephone prescription orders in retail and central fill pharmacies | SECTION 8 - CANCELLED | — |
| 044 | Pharmaceutical consultation; consulting with patients regarding the administration of medicine and the use of medical devices; providing a physician resource for clinical questions about medications; providing a website featuring information about, and through which, customers can obtain information about general health topics, pharmaceutical therapies and disease state management; providing medical information regarding patients, prescription drugs and drug therapy; providing health care information and consulting services in the field of disease management and medical condition management; providing medical information regarding patients, prescription drugs and drug therapy; developing and managing comprehensive programs involving drug therapy and physican support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; therapeutic pharmaceutical services, namely, the development and management of comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; drug utilization review dispensing services, namely, identifying possible drug to drug interactions prior to dispensing new prescribed medications and possible drug allergic reactions given a patient's drug allergy history | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2020 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 10, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 22, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 10, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 20, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 19, 2013 | ALIE | ASSIGNED TO LIE | — |
| Aug 6, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2013 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 5, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 5, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 10, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2013 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2012 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |